Clinical trial

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide…

NCT00422240 · Galderma R&D, Industry · Completed

Key facts

NCT number NCT00422240
Title Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
Official title A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel Compared With Adapalene Topical Gel, 0.1%; Benzoyl Peroxide Topical Gel, 2.5% and Topical Gel Vehicle in Subjects With Acne Vulgaris
Lead sponsor Galderma R&D, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Acne Vulgaris
Intervention type Drug
Interventions Adapalene/Benzoyl Peroxide, Adapalene Gel, 0.1%, Benzoyl Peroxide Gel 2.5%, Gel Vehicle
Enrollment 1,668
Start date Jun 27, 2006
Primary completion Jul 12, 2007
Completion Jul 12, 2007
First posted Jan 15, 2007
Last update posted Apr 15, 2024
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies